![Sergio Quezada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sergio Quezada
Founder at ACHILLES THERAPEUTICS PLC
Net worth: 304 204 $ as of 2024-06-29
Network origin in Sergio Quezada first degree
Entity | Entity type | Industry | |
---|---|---|---|
University College London
226
| College/University | Other Consumer Services | 226 |
Public Company | Pharmaceuticals: Major | 17 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Sergio Quezada via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
BP PLC | Integrated Oil | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
The Medical Research Council
![]() The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
RA Capital Management LP
![]() RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Analyst-Equity | |
SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
University of Oxford | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Imperial College London | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree | |
The University of Manchester | College/University | Director/Board Member Graduate Degree | |
University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Doctorate Degree Graduate Degree | |
The University of Southampton | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
London School of Economics & Political Science | College/University | Masters Business Admin Graduate Degree | |
University of Warwick | College/University | Corporate Officer/Principal | |
The Open University | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Surrey | College/University | Graduate Degree Undergraduate Degree | |
Sapienza University of Rome | College/University | Undergraduate Degree | |
University of Mysore | College/University | Undergraduate Degree | |
PricewaterhouseCoopers LLP (United Kingdom)
![]() PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
London Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Human Resources Officer | |
Bayes Business School | College/University | Graduate Degree Graduate Degree | |
NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
King's College London | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Doctorate Degree Graduate Degree | |
TISSUE REGENIX GROUP PLC | Medical Specialties | Director/Board Member | |
High Speed Two (HS2) Ltd.
![]() High Speed Two (HS2) Ltd. Other TransportationTransportation High Speed Two (HS2) Ltd. provides rail transportation services. It engages in developing and promoting the high speed rail network. The firm offers Y-shaped rail network providing direct high speed rail links between London and Birmingham. The company was founded in January 2009 and is headquartered in London, the United Kingdom. | Other Transportation | Director/Board Member | |
The Royal College of Surgeons of England | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
TENWOW INTERNATIONAL HOLDINGS LIMITED | Beverages: Alcoholic | Director/Board Member | |
University College London Hospitals NHS Foundation Trust
![]() University College London Hospitals NHS Foundation Trust Hospital/Nursing ManagementHealth Services University College London Hospitals NHS Foundation Trust provides first-class acute and specialist services in six hospitals in central London, UK. The British company's mission is to deliver top-quality patient care, excellent education, and world-class research. The company also offers events, classes, and workshops at the Macmillan Support and Information Service (MSIS) and an audiological service for GPs who would like to refer patients for age-related audiological assessments. Additionally, the company provides information about the sarcoma service and hearing therapists who work with adults who have hearing loss and associated disorders, such as tinnitus and hyperacusis, and other forms of hypersensitivity. The company is ultimately controlled by the Government of United Kingdom. | Hospital/Nursing Management | Director/Board Member Corporate Officer/Principal | |
The Yale University Dramatic Association | Director/Board Member | ||
Syndicate Room Ltd.
![]() Syndicate Room Ltd. Investment ManagersFinance Syndicate Room Ltd (Syndicate Room) is a venture capital firm founded in 2011 by Gonçalo de Vasconcelos and Tom Britton. The firm is headquartered in Cambridge, UK. | Investment Managers | Private Equity Investor | |
University Hospitals Coventry & Warwickshire NHS Trust
![]() University Hospitals Coventry & Warwickshire NHS Trust Hospital/Nursing ManagementHealth Services University Hospitals Coventry & Warwickshire NHS Trust provides healthcare services. The non-profit company is based in Coventry, UK and has subsidiaries in the United Kingdom. The British company was founded in 1992. The CEO is Andrew Hardy. | Hospital/Nursing Management | Corporate Officer/Principal | |
Freeline Therapeutics Ltd.
![]() Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder | |
Oxford Seed Fund /Venture Capital/
![]() Oxford Seed Fund /Venture Capital/ Investment ManagersFinance Oxford Seed Fund /Venture Capital/ is a venture capital arm of Saïd Business School, founded in 2012. The firm is headquartered in Oxford, United Kingdom. | Investment Managers | Director/Board Member | |
Achilles Therapeutics UK Ltd.
![]() Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer Founder Director/Board Member Founder | |
Suzhou Connect Biopharma Co. Ltd.
![]() Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Director/Board Member | |
NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
89Bio Ltd.
![]() 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Part of 89bio, Inc., 89Bio Ltd. is an Israeli company that develops therapies and drugs for the treatment of patients living with nonalcoholic steatohepatitis. The company is based in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Royal Free Hospital Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Company Holdings Ltd.
![]() McKinsey & Company Holdings Ltd. Financial ConglomeratesFinance Part of McKinsey & Co., Inc., McKinsey & Company Holdings Ltd. is a consulting firm that partners with leaders on strategy, innovating to net zero, leading with tech, and building capabilities for a sustainable, inclusive, growing future. The company is based in London, UK. The British company specializes in Consumer Packaged Goods and has conducted research, articles, and reports on the changes that matter most for the challenges and opportunities ahead. The company was founded in 2011 by Brian K. Stafford. | Financial Conglomerates | Corporate Officer/Principal | |
RA Capital Management LP (Private Equity)
![]() RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor | |
ITEOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ACRIVON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
FREELINE THERAPEUTICS HOLDINGS PLC | Biotechnology | Founder | |
The Institute for Fiscal Studies (Research Firm) | Investment Managers | Economist Analyst-Equity | |
DAY ONE BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
MINERALYS THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
London First | Miscellaneous Commercial Services | Chief Executive Officer | |
Crossrail Ltd.
![]() Crossrail Ltd. Other TransportationTransportation Crossrail Ltd. provides railway transportation services. It offers tunneling and funding services. The firm has been set up to build the new railway that will become known as the Elizabeth line when it opens through central London in 2018. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Other Transportation | Director/Board Member |
Statistics
International
United Kingdom | 32 |
United States | 11 |
Israel | 3 |
Italy | 2 |
India | 2 |
Sectoral
Consumer Services | 19 |
Health Technology | 15 |
Finance | 7 |
Commercial Services | 4 |
Transportation | 3 |
Operational
Director/Board Member | 210 |
Corporate Officer/Principal | 153 |
Undergraduate Degree | 57 |
Independent Dir/Board Member | 47 |
Chairman | 41 |
Most connected contacts
Insiders | |
---|---|
Edwin Moses | 35 |
David Knox | 27 |
Junaid Bajwa | 18 |
DeAnne Shirley Julius | 17 |
Derek DiRocco | 17 |
Julie O'Neill | 16 |
Bernhard R. M. Ehmer | 16 |
Carsten Boess | 15 |
Julia Prescot | 15 |
Sarah Whitney | 15 |
Ian Dato | 13 |
José-Alain Sahel | 13 |
Christopher Mason | 12 |
Mark Lowdell | 12 |
Dame Angela Strank | 11 |
- Stock Market
- Insiders
- Sergio Quezada
- Company connections